1-20 of 30 < first | prev | | last >
  • Generics Surge Forward

    AAM Access! 2019 makes it clear that generics have earned their seat at the table

    Karen Langhauser, Chief Content Director
  • Preparing for the Upsurge in Pharma Cyber Attacks

    In 2019, the number of connected OT devices will continue to grow exponentially and so will the OT security threat landscape.

    Yoni Shohet, Co-founder and VP of Business Development, SCADAfence
  • Excipients Fit for 21st Century Medicine

    DuPont's novel excipient is designed to better stabilize biologics

    Joshua S. Katz, Abigail Nolin, Benjamin A. Yezer, and Susan Jordan, DuPont Nutrition and Health
  • The Case for Predictive Maintenance

    Leveraging data will not only help pharma predict asset failures, but also eliminate them

    Sean Otto, Ph.D., VP Analytics, Cyient Insights
  • The Case for Outsourcing Buffer Preparation in Pharma

    Why manufacturers are seeking alternative options to in-house preparation.

    Dr. Becky Moore, Senior Global Product Manager Bioprocess Liquids; Genevieve E. Brau, Senior Manager, Global Market Development; Remko Clasen, Senior Market Development Manager, Thermo Fisher Scientific
  • Spotlight on Data Integrity

    How laboratory information management systems are helping pharma stay compliant

    Kimberly Remillard, Senior Regulatory Affairs Specialist for Digital Science, Thermo Fisher Scientific
  • Changing Cupid's Contract

    Pharma CMOs are sharpening their arrows and getting noticed

    Karen Langhauser, Chief Content Director
  • Sustainable Drugs From the Start

    China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs

    Karen Langhauser, Chief Content Director
  • CMOs on Fire

    Four contract manufacturers who are redefining what it means to outsource

  • Build Biologics Not Barriers

    iBio’s unique partnership with Beijing’s CC-Pharming will bring economical, plant-derived rituximab to China

    Karen Langhauser, Chief Content Director
  • Rethinking Isolation

    Berkshire Sterile Manufacturing’s souped-up isolator system offers a first-of-its-kind process for sterile manufacturing

    Meagan Parrish, Senior Editor
  • External Partnerships, Redefined

    Why building the right manufacturing partnerships is fundamental to pharma’s journey

    Leila Schwery-Bou-Diab, Vice President, Partnerships and External Supply, The Pharmaceutical Companies of Johnson & Johnson (Janssen)
  • Automate or Fail

    If pharma companies truly want to succeed when it comes to drug development, lab automation needs to play a leading role

    Piero Zucchelli, CEO and founder, Andrew Alliance
1-20 of 30 < first | prev | | last >